ImpediMed Limited
Explore this company’s associated devices, FDA decisions and regulatory history.

ImpediMed Limited
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name ImpediMed Limited. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jan 28, 2026 to Aug 17, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code DSB appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Suite 31c, 12-18 Tryon Rd., Lindfield, 2070, AU. Recorded on K260224, decision dated Aug 17, 2026.
Device categories in this collection
Plethysmograph, Impedance; Monitor, Extracellular Fluid, Lymphedema, Extremity.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ImpediMed Limited | 510(k) clearance | Aug 17, 2026 | FDA | |
| ImpediMed Limited | 510(k) clearance | Jan 28, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.

